EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
63.50
0.00 (0.00%)
At close: May 18, 2026
5.83% (1Y)
| Market Cap | 113.30M +17.2% |
| Revenue (ttm) | 9.43M +1.7% |
| Net Income | 2.46M +71.3% |
| EPS | 1.38 |
| Shares Out | 1.78M |
| PE Ratio | 46.08 |
| Forward PE | n/a |
| Dividend | 3.83 (6.03%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 9 |
| Average Volume | 139 |
| Open | 63.50 |
| Previous Close | 63.50 |
| Day's Range | 63.50 - 63.50 |
| 52-Week Range | 59.00 - 65.50 |
| Beta | n/a |
| RSI | 56.26 |
| Earnings Date | Jul 24, 2026 |